AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 290: L51-L58, 2006. First published September 9, 2005; doi:10.1152/ajplung.00028.2005
1040-0605/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/L51    most recent
00028.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lomas-Neira, J.
Right arrow Articles by Ayala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lomas-Neira, J.
Right arrow Articles by Ayala, A.

Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge

Joanne Lomas-Neira,1 Chun-Shiang Chung,2 Mario Perl,2 Stephen Gregory,2 Walter Biffl,2 and Alfred Ayala2

1Department of Cell and Molecular Biology, University of Rhode Island, Kingston; and 2Shock-Trauma Research Laboratories in the Division of Surgical Research, Department of Surgery, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island

Submitted 18 January 2005 ; accepted in final form 31 August 2005


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Acute lung injury (ALI) is identified with the targeting/sequestration of polymorphonuclear leukocytes (PMN) to the lung. Instrumental to PMN targeting are chemokines [e.g., macrophage inflammatory protein-2 (MIP-2), keratinocyte-derived chemokine (KC), etc.] produced by macrophage, PMN, and other resident pulmonary cells. However, the relative contribution of resident pulmonary macrophages as opposed to PMN in inducing ALI is poorly understood. We therefore hypothesize that depletion of peripheral blood PMN and/or the oblation of a macrophage-mediated PMN chemokine signal (via macrophage deficiency) will reduce the inflammation and ALI observed in mice following hemorrhage (Hem) and subsequent sepsis (CLP) in our murine model of ALI. To examine this we pretreated mice with either 500 µg anti-mouse Gr1 antibody/animal (to deplete PMN) or subjected mice deficient in mature macrophage (B6C3Fe-a/a-CsF1op) to Hem (90 min at 35 ± 5 mmHg) followed by resuscitation. Twenty-four hours post-Hem, mice were subjected to CLP and killed 24 h later, and lung tissue samples were collected. Our data showed that in the absence of either peripheral blood PMN or mature tissue macrophages there was a suppression of IL-6, KC, and MIP-2 levels in lung tissue from Hem/CLP mice as well as a reduction in PMN influx to the lung and lung injury (bronchoalveolar lavage fluid protein). In contrast, lung tissue IL-10 and TNF-{alpha} levels were suppressed in the macrophage-deficient Hem/CLP mice compared with PMN-depleted Hem/CLP mice. Together, these data suggest that both the PMN and the macrophage are required to induce inflammation seen here, however, macrophage not PMN regulate the release of IL-10, independent of local changes in TNF.

acute lung injury; sepsis; mouse; neutropenic; macrophage deficient


ACUTE LUNG INJURY (ALI) is a progressive syndrome associated with significant mortality in trauma/sepsis patients (44). What has been observed is that for trauma patients there appears to be a period of time following their initial injury where a significant risk exists for the development of ALI upon exposure to a secondary infectious challenge. In this respect, the accumulation of activated neutrophils found in lung tissue from patients with severe inflammatory lung injury is suggested to play a significant role in the development of ALI. In a nonpathological immune response, neutrophils targeted to the lung are cleared once the invading pathogen has been eliminated. Our laboratory and others have found that in the pathogenesis of ALI, neutrophil function becomes dysregulated leading to their sequestration in the lung where their presence is associated with tissue injury (11, 28, 36).

Neutrophils are essential first responders in host defense. Upon recruitment to sites of infection and inflammation they release proteolytic enzymes and reactive oxygen species targeting/killing invading pathogens. Instrumental to neutrophil migration to the lung are chemokines produced both locally (by tissue macrophage and lung tissue endothelium) as well as systemically (distal inflammatory sites) (7, 15, 48). The relationship between systemic and local environmental responses involves a balance coordinated by cell-to-cell interactions as well as the production of specific pro- and anti-inflammatory cytokines (4, 15, 16, 32).

An example of this relationship in the lung is the production of a neutrophil chemoattractant, macrophage inflammatory protein-2 (MIP-2), by tissue macrophages and bronchoalveolar epithelial cells in response to inflammatory stimuli. Neutrophils, in response to migratory signaling, cross the endothelium, and stimulate the release of IL-10 (a predominantly anti-inflammatory modulator of the immune response) (14) ostensibly from alveolar macrophages (19, 24, 37, 40). A hypothesis for neutrophil associated stimulation of IL-10 release from alveolar macrophage has been presented by Fadok et al. and Lucas et al (10, 29). Their studies have shown that phagocytosis of apoptotic neutrophils stimulates production of IL-10 by macrophage. The release of IL-10 is believed to play a role in suppressing cytokine production and the phagocytic activity of alveolar macrophages (14, 19, 24, 40). In this scenario, neutrophils serve as both a pro- and anti-inflammatory stimuli, interacting with both barrier (endothelial cells) and immune cell populations. Additionally, proinflammatory cytokines serve to up-regulate the expression of intercellular adhesion molecule-1 (ICAM-1) on endothelial cells, increasing neutrophil adhesion and migration from the circulation through the endothelium into the lung (7, 31, 33). These examples demonstrate the coordinated participation and interactions of resident cells in the immune response.

In previous experiments we have shown that antibody neutralization of MIP-2 abrogated the extent of inflammatory potential for donor neutrophil priming following hemorrhage in neutropenic recipients subjected to septic challenge [cecal ligation and puncture (CLP)] (28). The reduction in MIP-2 levels coincided with a decrease in lung tissue levels of IL-6 and myeloperoxidase (MPO) activity (neutrophil influx) and increased IL-10 compared with isotype-treated controls. However, as both neutrophils and resident pulmonary macrophage can contribute to the release of MIP-2, it was unclear what significance these two cellular sources of MIP-2 individually played in the development of ALI.

On the basis of these data, observations from other laboratories mentioned above, and in continuity with our previous studies (2628) we sought to further investigate the contributions of neutrophils as well as macrophage to the pathogenesis of ALI in our model of hemorrhage-induced neutrophil priming for ALI. We hypothesized not only that if mice were depleted of peripheral blood neutrophils and/or mice were deficient in chemokine-producing mature macrophages, they would exhibit reduced indexes of inflammation and lung injury following hemorrhage and subsequent septic challenge, but that these phagocytic lineages would make different contributions to this process.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Reagents

Keratinocyte-derived chemokine (KC) and MIP-2 monoclonal capture antibody and secondary detection antibody for ELISA assays were purchased from R&D Systems (Minneapolis, MN). Mouse IL-6, IL-10, and TNF-{alpha} ELISA kits were purchased from BD Bioscience (San Diego, CA). Antibodies for immunohistochemistry were purchased BD Pharmingen (San Jose, CA),and fluorescent streptavidin conjugates were purchased from Molecular Probes (Eugene, OR). All other chemicals were analytical reagent grade and purchased from Sigma Chemical (St. Louis, MO).

Mice

Male C3H/HeN mice (Charles River Laboratories, Wilmington, MA) 7–9 wk of age were used for neutrophil depletion experiments. Mice deficient in macrophage colony-stimulating factor-1 (M-CSF-1), 6–7 wk of age, colony-stimulating factor (CSF-1), B6C3Fe-a/a-CsF1° p (op–/–), and an untyped background control strain (op –/+) from The Jackson Laboratory (Bar Harbor, ME) were used for macrophage depletion experiments. Morphological assessment of lung macrophage deficiency via immunohistochemical staining for Mac-3 antigen (CSF-1R/CD115) is ~70% in op–/– vs. op–/+ control mice. The op–/– mice do not however, exhibit a significant decline in the number of circulating blood polymorphonuclear leukocytes (PMN). Experiments were performed in accordance with National Institutes of Health guidelines and approval from the Animal Use Committee of Rhode Island Hospital.

Neutrophil Depletion

Mice were depleted of resident neutrophils via intraperitoneal injection of 500 µg of rat anti-mouse neutrophil antibody, anti-Gr1 (clone RB6–8C5, rat IgG2b), per mouse 48 h before hemorrhage. Efficacy of antibody treatment was determined to be >95% based on reduction of the number of neutrophils in peripheral blood smears assessed 48 and 60 h posttreatment. The lack of circulating neutrophils at this time point, during the priming stimulus of hemorrhagic shock, prevents neutrophil activation by proinflammatory mediators released in response to hemorrhage (28). Alternatively, histological assessment of the number of CD115+ cells (macrophage) in the lungs indicated that antibody treatment did not reduce this cell population.

Mouse Hemorrhage/Sepsis Model for ALI

Hemorrhage. The hemorrhage model we have used for these experiments has been previously described (2). In brief, mice were anesthetized with methoxyflurane and restrained in supine position, and catheters were inserted into both femoral arteries. Anesthesia was discontinued, and blood pressure was continuously monitored through one catheter attached to a blood pressure analyzer (BPA; MicroMed, Louisville, KY). When fully awake, as determined by a mean blood pressure of ~95 mmHg, the mice were bled over a 5- to 10-min period to a mean blood pressure of 30 mmHg (±5 mmHg) and kept stable for 90 min. Immediately following hemorrhage, mice were resuscitated intravenously with Ringer lactate at four times drawn blood volume. After resuscitation, arteries were ligated, catheters removed, and catheter sites sutured closed. Sham hemorrhage (SHem), was performed as a control, these mice were anesthetized and restrained, and their femoral arteries were ligated, but no blood was drawn.

Polymicrobial sepsis. Twenty-four hours posthemorrhage (or sham hemorrhage), sepsis was induced as a secondary challenge via CLP as previously described (3). To summarize, mice were anesthetized with methoxyflurane and restrained in supine position. A 1-cm midline incision was made; the cecum was ligated with 5-0 silk thread and punctured twice with a 21-gauge needle. The cecum was then replaced, the incision was sutured, and lidocaine was applied, abdominal layer then skin. Mice were resuscitated with 1 ml of Ringer lactate subcutaneously and returned to their cages.

Sample Collection

Twenty-four hours post-CLP mice were killed with an overdose of methoxyflurane.

Blood was collected via cardiac puncture into heparinized syringes. Blood samples were centrifuged, and plasma was collected and stored at –70°C for later cytokine analysis.

Bronchoalveolar lavage (BAL) fluid was collected to assess protein concentration as an index of lung permeability (injury). The trachea was exposed via a midline incision and cannulated with a sterile polypropylene 18-gauge catheter. The lungs were gently lavaged with 0.6 ml of saline three times for an average of 1 ml of lavage fluid total per lung. Lavage fluid was centrifuged 1,000 g for 8 min at 4°C. Protein concentration in lavage fluid was assessed by Bradford assay.

Lung tissue was harvested for assessment of neutrophil influx (esterase+ cells), bronchial endothelial cell ICAM-1 expression, CSF-1R/CD115 expression (macrophage receptor), and tissue architecture. Due to the degradation of tissue architecture observed in lavaged mouse lungs, additional mice were used for histological assessment. Mice were killed with an overdose of methoxyflurane (Pitman-Moore, Mundelein, IL), blood was then drawn from heart via cardiac puncture, the trachea was cannulated, and lungs were inflated to 25 cm of pressure with formalin. Lungs were excised and snap frozen in liquid nitrogen in embedding molds with optimal cutting temperature media (TissueTek, Elkhart, IL) for later processing of frozen sections.

Methods of Assessment

Cytokine and chemokine ELISAs. ELISAs for IL-6, IL-10, KC, MIP-2, and TNF-{alpha} were performed as per manufacturer's protocol on lung tissue homogenates collected from experimental mice.

Lung MPO activity. MPO activity as an assessment of neutrophil influx was measured according to established protocols (28). In brief, lung tissue was homogenized in 0.5 ml of 50 mM potassium phosphate buffer, pH 7.4, and centrifuged at 40,000 g at 4°C for 30 min. The supernatant was reserved for cytokine analysis. The remaining pellet was resuspended in 0.5 ml of 50 mM potassium buffer pH 6.0 with 0.5% hexadecyltrimethylammonium bromide, sonicated on ice, and then centrifuged at 12,000 g at 4°C for 10 min. Supernatants were then assayed at a 1:20 dilution in reaction buffer (530 nmol/l o-dianisidine, 150 nmol/l H2O2 in 50 mM potassium phosphate buffer), and read at 490 nm.

Immunohistochemical staining for assessment of neutrophil influx and tissue architecture. Staining for leukocyte-specific esterase, Naphthol AS-D chloroacetate esterase (Sigma Diagnostics, St. Louis, MO), was performed on frozen tissue sections fixed in citrate-acetone-formaldehyde. Slides were incubated in a solution of sodium nitrate, Fast Red Violet BL base solution, TRIZMAL 6.3 buffer, and Naphthol AS-D chloroacetate solution in deionized water for 15 min at 37°C. After rinsing, slides were counterstained with Gills hematoxylin solution and coverslipped. Stained lung sections were examined microscopically for morphology and positively stained cells. To establish the total number (%) of cells (per field) that were neutrophils (esterase+) present in the sample, tissue sections were randomly screened (7–8 fields/slide) at x400 (25 µm2/field).

Bronchial epithelial cell ICAM-1 expression on endothelial cells in neutrophil-depleted and macrophage-deficient mouse lungs. Acetone-fixed frozen lung tissue sections from neutrophil-depleted and macrophage-deficient mice were cut and mounted on glass microscope slides. Immunohistochemistry for CD-144/vascular endothelial (VE)-cadherin (an endothelial cell marker) and CD-54/ICAM-1 was performed as per manufacturer's protocol (BD Pharmingen). After rinsing to remove mounting media and blocking with PBS plus 5% serum for 30 min at 37°, slides were incubated with purified hamster antibody against mouse CD-54/ICAM-1 for 1 h at room temperature in a humidity chamber. Slides were rinsed and incubated with a biotinylated mouse anti-hamster IgG2b antibody for 30 min at room temperature and then rinsed. Slides were then incubated with a streptavidin Alexa Fluor 594 conjugate (Molecular Probes, Eugene, OR) for 30 min, rinsed, and compared with negative control slides (without primary). Slides were then incubated with purified rat antibody against mouse CD-144/VE-cadherin for 1 h at room temperature in a humidity chamber. Slides were rinsed and incubated with a biotinylated mouse anti-rat IgG2a antibody for 30 min at room temperature and then rinsed. Slides were then incubated with a streptavidin Alexa Fluor 488 conjugate for 30 min, rinsed, and compared with negative control slides (without primary). Slides were then coverslipped with a mounting medium for fluorescence microscopy with 4',6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA), for visualization of intact cells. Confocal images were acquired with a Nikon PCM 2000 (Nikon, Mellville, NY) using the argon (488) and the green helium-neon (543) lasers. Serial optical sections were performed with Simple 32, C-imaging computer software (Compix, Cranberry Township, PA). Z-series sections were collected at 0.6 µm with a x60 PlanApo lens and a scan zoom of x2 and a x40 PlanApo lens and a scan zoom of x1. Images were processed, overlaid, and reconstructed/merged in NIH Image J (National Institutes of Health, Springfield, VA). Adobe Photoshop was used in the assembly of figures.

Statistical Analysis

Data was expressed as means ± SE of five mice examined in each group. Statistical error was determined by one-way ANOVA; the post hoc test was Tukey's. Calculations were performed with SigmaStat for Windows version 2.03. P values <0.05 were considered significant.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Absence of Both Peripheral Blood Neutrophils and Mature Macrophage Suppress Proinflammatory Response

Levels of IL-6 were assessed in lung tissue from antibody-depleted neutropenic mice (Gr1–) and macrophage-deficient mice (op–/–) (Fig. 1). Mice subjected to hemorrhage (Hem)/CLP, but not antibody depleted of neutrophils (Ctrl Hem/CLP) or op background animals (op–/+ Hem/CLP), showed a significant increase in lung tissue IL-6 compared with their respective SHem/CLP groups. Both the deficiency of circulating neutrophils (induced by anti-Gr1 pretreatment) as well as a lack of chemokine-synthesizing macrophages (op–/– mice) significantly reduced the increase in Hem/CLP lung tissue levels of IL-6 compared with background/controls.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1. Lung tissue content of IL-6. Lung tissue homogenate levels of IL-6 were significantly reduced in both the neutrophil-depleted (anti-Gr1-treated) and macrophage-deficient mice (op mice) compared with their Hem/CLP controls. *P < 0.05 vs. respective SHem/CLP group. @P < 0.05 vs. op–/– Hem/CLP; n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
Suppression of Chemokine Production Was Observed in Both Neutrophil-Depleted and Macrophage-Deficient Mice

The increased lung tissue levels of neutrophil chemotactic chemokines, KC and MIP-2, observed in IgG-treated Ctrl Hem/CLP or op–/+ Hem/CLP background mice were significantly suppressed in lung tissue from neutropenic mice (Gr1–) and macrophage-deficient mice (op–/–) following Hem/CLP (Fig. 2, A and B).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2. A-B. Lung tissue levels of chemokines KC and MIP-2 were significantly elevated in the Hem/CLP control/background groups relative to their respective SHem/CLP groups in both the neutrophil depletion and macrophage deficiency studies. A suppression of KC and MIP-2 to SHem/CLP levels was observed in both the neutrophil depleted (Gr1–) and macrophage deficient (op–/–) Hem/CLP mice. *P < 0.05 vs. respective SHem/CLP group. @P < 0.05 vs. op–/– Hem/CLP; n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
Neutrophil Depletion but not Macrophage Deficiency Restores IL-10

In those Ctrl and op–/+ mice subjected to Hem/CLP, there was a small but consistent decline in lung tissue IL-10 levels vs. Ctrl and op–/+ animals subjected to sham/CLP. Mice depleted of peripheral blood neutrophils before Hem/CLP (Gr1–) showed a significant increase in lung tissue levels of anti-inflammatory cytokine IL-10 above that of their SHem/CLP control mice with or without prior anti-Gr1 treatment (Fig. 3). However, in the absence of mature tissue macrophages, such an increase above background op–/+ SHem/CLP mouse levels was not observed in the op–/– Hem/CLP mice.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3. Lung tissue IL-10 content in the macrophage deficient SHem/CLP, Hem/CLP and control Hem/CLP groups remained at control SHem/CLP levels. Alternatively, lung tissue IL-10 levels were significantly elevated in neutrophil depleted (Gr1–) Hem/CLP mice compared with control Hem/CLP mice. *P < 0.05 vs. respective SHem/CLP group. n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
Macrophage Deficiency Significantly Attenuates TNF-{alpha} Production in Lung Tissue

Lung tissue levels of TNF-{alpha} were significantly elevated above SHem/CLP levels for all Hem/CLP groups (Fig. 4). Furthermore, this effect of Hem/CLP was not attenuated by the depletion of PMN. However, macrophage deficiency (op–/–) attenuated overall TNF-{alpha} levels in both the Hem/CLP and SHem/CLP mice.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4. Lung tissue levels of TNF-{alpha} increased in all Hem/CLP groups relative to their respective SHem/Hem group. However, a significant reduction of TNF-{alpha} was observed in the macrophage deficient (op–/–) SHem/CLP and Hem/CLP groups compared with (op–/+) SHem/CLP and Hem/CLP controls. *P < 0.05 vs. respective SHem/CLP group. @P < 0.05 vs. op–/– Hem/CLP; n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
Neutrophil Influx Significantly Blocked

Subjecting Ctrl and op–/+ mice to Hem/CLP markedly increased lung tissue MPO levels compared with respective SHem/CLP groups (Fig. 5A). This increase in tissue MPO was significantly attenuated by both anti-Gr1 treatment (Gr1–) and the genetic deficiency in mature tissue macrophages (op–/–) in mice subjected to Hem/CLP.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5. A: myeloperoxidase activity increased in lung tissue from the (op–/+) and Ctrl Hem/CLP mice compared with their respective SHem/CLP groups. Less of an increase was observed in the macrophage deficient (op–/–) Hem/CLP mice, however, there was no significant increase in the (Gr1–) Hem/CLP mice. B: % neutrophil-specific esterase+ cells in lung tissue sections increased above SHem/CLP levels in both the op–/+ background and Ctrl control groups. Macrophage deficiency (op–/–) and neutrophil depletion (Gr1–) suppressed this increase in these mice subjected to Hem/CLP. *P < 0.05 vs. respective SHem/CLP group. @P < 0.05 vs. op–/– Hem/CLP; n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
Decrease in Neutrophil-Specific Esterase+ Cells in Lung Tissue Sections Is Similar in Both Neutrophil Depletion and Macrophage-Deficient Mice

Supporting MPO data, lung tissue histology from (Gr1–) Hem/CLP (neutropenic mice) and op–/– Hem/CLP (Hem/macrophage-deficient) mice show a significant reduction in the percentage of neutrophil-specific esterase+ cells compared with their respective Hem/CLP control/background groups (Fig. 5B).

Decrease in BAL Fluid Protein Similar in Both Neutrophil Depletion and Macrophage-Deficient Mice

Protein concentration in BAL fluid was measured to assess lung leakage, an indicator of lung tissue injury. Irrespective of whether the mice were Ctrl or were op–/+ background animals, subjecting them to Hem/CLP as opposed to SHem/CLP markedly increased the level of BAL fluid protein (Fig. 6). Further, neutrophil depletion (Gr1–) or macrophage deficiency (op–/–) significantly reduced levels of protein in lung lavage fluid compared with their respective Hem/CLP control/background groups.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6. Protein concentration in bronchoalveolar lavage fluid from op–/+ and Ctrl Hem/CLP mice increased significantly compared with their respective SHem/CLP groups. The absence of mature macrophage (op–/–) and neutrophil depletion (Gr1–) in mice subjected to Hem/CLP diminished lavage fluid protein concentration to SHem/CLP levels. *P < 0.05 vs. respective SHem/CLP group. @P < 0.05 vs. op–/– Hem/CLP; n = 6 mice/group. #P < 0.05 vs. (Gr1–) Hem/CLP; 8 mice/group.

 
ICAM-1 Expression Suppressed on Endothelial Cells in Lungs of Macrophage-Deficient Mice

A low level of ICAM-1 is constitutively expressed on endothelial cells in lung tissue (38). In the merged images shown in Fig. 7, endothelial cells stain fluorescent green, and ICAM-1 stains fluorescent red; the colocalization of these colors is visualized by the pseudocolor yellow. In the presence of significantly elevated IL-10 and neutropenia, lung tissue sections from (Gr1–) Hem/CLP mice (Fig. 7B) expressed levels of endothelial cell associated ICAM-1 (yellow) comparable to the Ctrl Hem/CLP mice (Fig. 7A). An upregulation of endothelial cell-associated ICAM-1 (yellow) expression was not visualized in lung tissue sections from the macrophage-deficient mice subjected to Hem/CLP (Fig. 7D) compared with their Hem/CLP background (Fig. 7C).



View larger version (177K):
[in this window]
[in a new window]
 
Fig. 7. Merged image CD-54/ICAM-1 expression, visualized by streptavidin Alexa Fluor 594 staining (red) and CD-144/vascular endothelial (VE)-cadherin (endothelial cell marker) visualized by streptavidin Alexa Fluor 488 (green). Colocalization of ICAM-1 on endothelial cells (red plus green) is shown as yellow pseudocolor on stained tissue produced by the image merge. ICAM-1 expression on endothelial cells remained elevated to the levels of Hem/CLP background control (A) in lung tissue sections from neutrophil-depleted mice, (Gr1–) Hem/CLP (B). In contrast, ICAM-1 expression was not upregulated compared with Hem/CLP background control (C) for macrophage-deficient mice, op–/– Hem/CLP (D). Representative lung tissue sections from 8 mice/group; Image x120 (bar measures 10 µm) and insert x40 (bar of the insert measures 50-µm magnification.)

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We have previously demonstrated that hemorrhagic shock (90 min at 35 ± 5 mmHg) followed 24 h by septic challenge (CLP) induces, in the lungs of mice, changes in cytokine/chemokine profiles, neutrophil infiltration, and sequestration, and lung tissue injury similar to ALI encountered in a clinical setting of the shock/trauma patient (3, 28). In this study we have used this unique model of murine ALI to assess the neutrophil and macrophage contribution to associated inflammatory lung injury seen following hypotensive shock. Depletion of peripheral blood neutrophils was achieved through treatment with anti-Gr1 antibody 48 h before an initial priming stimulus, hemorrhage, thus preventing hemorrhage activation of neutrophils in circulation. Macrophage-associated studies were performed on mice genetically deficient in M-CSF-1. The op–/– mice (6–7 wk of age) used in our study lack, due to a point mutation, a major macrophage growth factor gene, colony stimulating factor-1 (M-CSF-1) (6, 8, 12, 42, 46). M-CSF-1 is the major growth factor associated with the maturation of tissue macrophages. Although M-CSF-1-independent macrophages have been identified, their phagocytic response is poor and population density low (13, 30, 46). This strain has been characterized by a number of investigators over the last 15 years (8, 12, 34, 35, 41, 46, 47). Labeled "osteopetrotic" due to their low number of osteoclasts, this murine strain has been shown to have defective differentiation of monocytes into osteoclasts and mature macrophage that exhibit reduced cytokine/chemokine expression (18).

These models, neutrophil depleted/mature macrophage deficient, and their backgrounds produce strain-specific perturbations in the local pulmonary immune response following Hem priming and subsequent septic challenge. Through comparison within each strain of their altered response following hemorrhagic shock and sepsis, a clearer picture can be resolved as to the contribution these cells make to the pathogenesis of ALI.

Antibody depletion of peripheral blood neutrophils greatly reduced indices of inflammation in these mice. This supports the hypothesis that neutrophils via hemorrhage induced priming have an enhanced capacity to traffic to the lung, where if subsequently stimulated (as with CLP) can contribute to local tissue injury. Because the depletion of neutrophils with anti-Gr1 and their absence from the lungs of (Gr1–) Hem/CLP mice markedly attenuated proinflammatory cytokine, IL-6, and levels of the chemokines KC and MIP-2, a potential requirement for the presence of neutrophils to potentiate the local lung inflammatory response is suggested. Theoretically, the sequence of events in the lung during an inflammatory response is recognized as progressing from MIP-2 production by stimulated macrophage to the targeting of PMN across the lung endothelium, which results in IL-10 production. This cascade of mediator and cellular interactions produces an efficient and regulated inflammatory response resolving in the elimination of invading pathogen and clearance of activated neutrophils. However, interference in the cellular interactions necessary for an effective immune response disrupts not only downstream events, but also those occurring concurrently. In the series of experiments reported in this study we found that by depleting the animal of neutrophils before shock, a broader disruption of inflammatory signaling was observed. By severely reducing the number of neutrophils in the peripheral blood, the signaling pathways stimulated through cellular interactions with activated neutrophils were disrupted. A decrease in circulating neutrophils with an increase of IL-10 is consistent with our previous findings where mice treated with anti-MIP-2 immediately posthemorrhage showed elevated IL-10, decreased MIP-2, and decreased MPO (PMN influx)(28). This data highlights the necessity of cell-cell interactions in the regulation of mediator expression.

The absence or diminution of neutrophil/endothelial cell (ICAM-1) interaction presents an additional disruption in the immune signaling pathway. Systemic activation of ICAM-1, via complement and/or TNF-{alpha} and IL-1{beta} increases intrapulmonary recruitment of neutrophils via lymphocyte function-associated Ag (LFA-1) receptor binding to ICAM-1(9, 23, 45). Peripheral blood lymphocytes also express the LFA-1 receptor and have been reported to migrate across the lung endothelium in response to antibody against LFA-1 as well as interactions with B and T cells (1, 5, 17, 21, 39). Additionally, as reported by van der Meeren et al. and others (1, 5, 21, 43), these emigrating lymphocytes were found to have the capacity to release IL-10. Our data showed an upregulation of ICAM-1 on lung endothelial cells in the presence of elevated IL-10 in neutrophil-depleted mice following hemorrhage and subsequent septic challenge (Fig. 7); this is in agreement with recent studies by Ledeboer et al. and Lisinski et al. (22, 25). Their studies show that although IL-10 suppressed extravasation of neutrophils and cytokine production, adhesion molecule expression was not similarly affected in response to chronic inflammation (22) or TNF-{alpha} and IL-1{beta} stimulation (22). In this scenario, despite neutropenia, the transendothelial migration of lymphocytes presents a level of complexity that although existing in the background control mice, prevents more than a speculative explanation for this outcome.

With respect to the macrophage-deficient mouse lungs, ICAM-1 expression was not upregulated compared with its background. However, in these mice neither IL-10 nor TNF-{alpha} was upregulated following hemorrhage and septic challenge. These findings suggest that disruption of macrophage-associated signaling represents a broader impact on the process and intensity of the inflammatory response.

Lung tissue levels of TNF-{alpha} remained elevated in the anti-Gr1 treatment group compared with Ctrl Hem/CLP group despite the significant reduction in neutrophils detected in the lungs of (Gr1–) Hem/CLP mice. The finding of increased expression of TNF-{alpha} in the presence of IL-10 is also not without precedence, as the neutrophil-depleted septic mice maintain a full complement of mature IL-10 producing macrophages in their lung compartment. In a recent study of trauma/hemorrhage in mice, Knoferl et al. (20) found both IL-10 and TNF-{alpha} to be produced by Kupffer cells in the liver.

Mice genetically deficient in M-CSF-1, a protein associated with macrophage survival, proliferation, and differentiation (6), also showed marked reduction in levels of inflammatory and chemotactic proteins. Alveolar macrophage are a major source of neutrophil chemokine MIP-2 (7, 48). Thus elimination of this reservoir should have also served to reduce the number of neutrophils chemotaxing to the lung, as we have observed here.

Additionally, macrophage are thought to be a potentially significant source for or respondent to IL-10 (40). The inability of macrophage-deficient (op–/–) mice to produce increased IL-10 levels as opposed to the neutrophil-deficient (Gr1–) Hem/CLP mice [as op–/–Hem/CLP mice had similarly reduced MPO levels/numbers esterase+ cells in their lungs as (Gr1–) Hem/CLP mice] is indicative of the role macrophage and not the neutrophil plays in regulating the anti-inflammatory cascade and the resolution of the immune response. Alternatively, the capacity of both neutrophil depletion and macrophage deficiency to comparatively suppress proinflammatory changes in local lung cytokine/chemokine implies a need for both cell types to potentiate the local tissue inflammatory response following shock and septic challenge. It also implies that anti-inflammatory events, like IL-10 release, while important to the eventual resolution of many inflammatory processes, are not the critical process in the development of ALI observed here.

In summary, the results described in this study support our hypothesis that the absence or suppression of either neutrophil or macrophage response reduce indexes of inflammation and lung injury following hemorrhage and subsequent septic challenge. Thus both cell types are essential to the pathological development of lung injury resultant from shock and sepsis. However, their contributions while interrelated are not wholly redundant.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This investigation was supported by National Heart, Lung, and Blood Institute Grant HL-73525 (to A. Ayala) and research funds from Lifespan/Rhode Island Hospital.


    ACKNOWLEDGMENTS
 
We thank Paul Monfils and Virginia Hovanesian, Core Research Laboratories, for assistance with histology and imaging.


    FOOTNOTES
 

Address for reprint requests and other correspondence: A. Ayala, Div. of Surgical Research, Aldrich 227, Rhode Island Hospital, 593 Eddy St., Providence, RI 02903 (e-mail: aayala{at}lifespan.org)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Ainslie MP, McNulty CA, Huynh T, Symon FA, and Wardlaw AJ. Characterisation of adhesion receptors mediating lymphocyte adhesion to bronchial endothelium provides evidence for a distinct lung homing pathway. Thorax 57: 1054–1059, 2002.[Abstract/Free Full Text]
  2. Ayala A, Chung CS, Lomas J, Grutkoski PS, Doughty LA, and Simms HH. A mouse model of priming for acute lung injury following shock. Shock 15: 83S, 2001.
  3. Ayala A, Chung CS, Lomas JL, Song GY, Doughty LA, Gregory SH, Cioffi WG, LeBlanc BW, Reichner J, Simms HH, and Grutkoski PS. Shock induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 161: 2283–2294, 2002.[Abstract/Free Full Text]
  4. Cassatella MA. The neutrophil: one of the cellular targets of interleukin-10. Int J Clin Lab Res 28: 148–161, 1998.[CrossRef][ISI][Medline]
  5. Chowdhury SA, Nagata M, Yamada K, Nakayama M, Chakrabarty S, Jin Z, Kotani R, and Yokono K. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA mAb and anti-CD8 mAb. Kobe J Med Sci 48: 167–175, 2003.
  6. Cohen PE, Nishimura K, Zhu L, and Pollard JW. Macrophages: important accessory cells for reproductive function. J Leukoc Biol 66: 765–772, 1999.[Abstract]
  7. Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, and Ward PA. Mechanisms of enhanced lung injury during sepsis. Am J Pathol 154: 1057–1065, 1999.[Abstract/Free Full Text]
  8. Dai XM, Zong XH, Sylvestre V, and Stanley ER. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 103: 1114–1123, 2004.[Abstract/Free Full Text]
  9. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S-329S, 1997.[Medline]
  10. Fadok VA, Bratton DL, Guthrie L, and Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol 166: 6847–6854, 2001.[Abstract/Free Full Text]
  11. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, and Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 161: 440–447, 1998.[Abstract/Free Full Text]
  12. Felix R, Cecchini MG, and Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127: 2592–2594, 1990.[Abstract]
  13. Felix R, Cecchini MG, and Hofstetter W. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5: 781–789, 1990.[ISI][Medline]
  14. Fernandez S, Jose P, Avdiushko MG, Kaplan AM, and Cohen DA. Inhibition of IL-10 receptor function in alveolar macrophages by toll-like receptor agonists. J Immunol 172: 2613–2620, 2004.[Abstract/Free Full Text]
  15. Garcia-Ramallo E, Marques T, Prats N, Beleta J, Kunkel SL, and Godessart N. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J Immunol 169: 6467–6473, 2002.[Abstract/Free Full Text]
  16. Guo RF and Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses in the lung: insights from the IgG immune complex model. Free Radic Biol Med 33: 303–310, 2002.[CrossRef][ISI][Medline]
  17. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25, 1992.[CrossRef][ISI][Medline]
  18. Jiang S, Naito M, Kaizu C, Kuwata K, Hasegawa G, Mukaida N, and Shultz LD. Lipopolysaccharide-induced cytokine and receptor expression and neutrophil infiltration in the liver of osteopetrosis (op/op) mutant mice. Liver 20: 465–474, 2000.[CrossRef][ISI][Medline]
  19. John M, Lim S, Seybold J, Jose P, Robichaud A, and O'Connor B. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 157: 256–262, 1998.[Medline]
  20. Knoferl MW, Angele MK, Diodato MD, Schwacha MG, Ayala A, Cioffi WG, Bland KI, and Chaudry IH. Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg 235: 105–112, 2002.[CrossRef][ISI][Medline]
  21. Kretschmer U, Bonhagen K, Debes GF, Mittrucker HW, Erb KJ, Liesenfeld O, Zaiss D, Kamradt T, Syrbe U, and Hamann A. Expression of selectin ligands on murine effector and IL-10-producing CD4+ T cells from non-infected and infected tissues. Eur J Immunol 34: 3070–3081, 2004.[CrossRef][ISI][Medline]
  22. Ledeboer A, Wierinckx A, Bol JGJM, Floris S, de Lavalette CR, De Vries HE, van den Berg TK, Dijkstra CD, Tilders FJH, and Van Dam A. Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol 136: 94–103, 2003.[CrossRef][ISI][Medline]
  23. Lentsch AB, Czermak BJ, Bless NM, Van Rooijen N, and Ward P. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am J Respir Cell Mol Biol 20: 692–698, 1999.[Abstract/Free Full Text]
  24. Lim S, Caramori G, Tomita K, Jazrawi E, Oates T, Chung KF, Barnes PJ, and Adcock IM. Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. Allergy 59: 505–514, 2004.[CrossRef][ISI][Medline]
  25. Lisinski TJ and Furie MB. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burggdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor-alpha. J Leukoc Biol 72: 503–511, 2002.[Abstract/Free Full Text]
  26. Lomas-Neira J, Chung CS, Grutkoski PS, Miller EJ, and Ayala A. CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J Leukoc Biol 76: 1–7, 2004.[Abstract/Free Full Text]
  27. Lomas-Neira JL, Chung CS, Wesche DE, Perl M, and Ayala A. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol 77: 1–8, 2005.[Free Full Text]
  28. Lomas JL, Chung CS, Grutkoski PS, LeBlanc BW, Lavigne L, Reichner J, Gregory SH, Doughty LA, Cioffi WG, and Ayala A. Differential effects of macrophage inflammatory protein-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cell transfer in mice. Shock 19: 358–365, 2003.[CrossRef][ISI][Medline]
  29. Lucas M, Stuart LM, Savill J, and Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 171: 2610–2615, 2003.[Abstract/Free Full Text]
  30. Marks SC and Lane PW. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67: 2592–2594, 1976.
  31. Martinez-Mier G, Toledo-Pereyra LH, and Ward PA. Adhesion molecules in liver ischemia and reperfusion. J Surg Res 94: 185–194, 2000.[CrossRef][ISI][Medline]
  32. Miotla JM, Ridger VC, and Hellewell PG. Dominant role of L- and P-selectin in mediating CXC chemokine-induced neutrophil migration in vivo. Br J Pharmacol 133: 550–556, 2001.[CrossRef][ISI][Medline]
  33. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, and Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 142: 1739–1749, 1993.[Abstract]
  34. Naito M, Umeda S, Takahashi K, and Shultz LD. Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol Reprod Dev 46: 85–91, 1997.[CrossRef][ISI][Medline]
  35. Nowicki A, Szenajch J, Ostrowska G, Wojtowicz A, Wojtowicz K, Kruszewski AA, Maruszynski M, Aukerman SL, and Wiktor-Jedrzejczak W. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 65: 112–119, 1996.[CrossRef][ISI][Medline]
  36. Ogura H, Tanaka H, Koh T, Hashiguchi N, Kuwagata Y, Hosotsubo H, Shimazu T, and Sugimoto H. Priming, second-hit priming, and apoptosis in leukocytes from trauma patients. J Trauma 46: 774–781, 1999.[ISI][Medline]
  37. Oltmanns U, Schmidt B, Hoernig S, Witt C, and John M. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. Exp Lung Res 29: 315–328, 2002.
  38. Panes J, Perry MA, Anderson DC, Manning A, Leone B, Cepinskas G, Rosenbloom C, Miyasaka M, Kveitys PR, and Granger DN. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol Heart Circ Physiol 269: H1955–H1964, 1995.[Abstract/Free Full Text]
  39. Petruzzelli L, Maduzia L, and Springer TA. Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation. J Immunol 160: 4208–4216, 1998.[Abstract/Free Full Text]
  40. Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K, and Standiford TJ. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin-10. Infect Immun 69: 1394–1401, 2001.[Abstract/Free Full Text]
  41. Schonlau F, Schlesiger C, Ehrehen J, Grabbe S, Sorg C, and Sunderkotter C. Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasis. J Leukoc Biol 73: 564–573, 2003.[Abstract/Free Full Text]
  42. Stanley IJ and Burgess AW. Granulocyte macrophage-colony stimulating factor stimulates the synthesis of membrane and nuclear proteins in murine neutrophils. J Biol Chem 23: 241–258, 1983.
  43. Van der Meeren A, Squiban C, Gourmelon P, Lafont H, and Gaugler MH. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine 11: 831–838, 1999.[CrossRef][ISI][Medline]
  44. Weinacker AB and Vaszar LT. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 52: 221–237, 2001.[CrossRef][ISI][Medline]
  45. Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, Fuchs D, and Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 23: 729–736, 2003.[CrossRef][ISI][Medline]
  46. Wiktor-Jedrzejczak W and Gordon S. Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev 76: 927–947, 1996.[Abstract/Free Full Text]
  47. Wiktor-Jedrzejczak W, Sell KW, Szwech P, and Ahmed-Ansari A. Absence of CSF-1 in macrophage-deficient op/op mice has differential effects on macrophage colony stimulating activity (M-CSA) released by various organs and cells. Folia Histochem Cytobiol 33: 259–265, 1995.[Medline]
  48. Yoshie O, Imai T, and Nomiyama H. Chemokines in immunity. Adv Immunol 78: 57–110, 2001.[ISI][Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Zhao, J. W. Zmijewski, E. Lorne, G. Liu, Y.-J. Park, Y. Tsuruta, and E. Abraham
Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L497 - L504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. A. Bem, A. W. Farnand, V. Wong, A. Koski, M. E. Rosenfeld, N. van Rooijen, C. W. Frevert, T. R. Martin, and G. Matute-Bello
Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L314 - L325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Perl, C.-S. Chung, U. Perl, J. Lomas-Neira, M. de Paepe, W. G. Cioffi, and A. Ayala
Fas-induced Pulmonary Apoptosis and Inflammation during Indirect Acute Lung Injury
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 591 - 601.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Lahm, K. M. Patel, P. R. Crisostomo, T. A. Markel, M. Wang, C. Herring, and D. R. Meldrum
Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E865 - E871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W.-F. Fang, J. H. Cho, Q. He, M.-C. Lin, C.-C. Wu, N. F. Voelkel, and I. S. Douglas
Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L336 - L344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Frink, B. M. Thobe, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry
17beta-Estradiol inhibits keratinocyte-derived chemokine production following trauma-hemorrhage
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L585 - L591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron, and V. E. Laubach
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1018 - L1026.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/L51    most recent
00028.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lomas-Neira, J.
Right arrow Articles by Ayala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lomas-Neira, J.
Right arrow Articles by Ayala, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.